Filter by: patients
Home > Community Treatment Reports and Side Effects > Prinzide Treatment Report
What is Prinzide?

merck® is a brand name for the combination of lisinopril and hydrochlorothiazide. It is used for the treatment of hypertension.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Elevated blood pressure 2 1 Efficacy_moderate
Hypertension 1 1 Efficacy_slight

See all 3 patients currently taking Prinzide

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 0
Mild
 0
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Prinzide

Cramps in legs 1
Drug interactions 1
Pain in right heel 1

Reported Dosages

  12.5 mg-10 mg daily 12.5 mg-20 mg daily 25 mg-20 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Prinzide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 100%

See all 1 patient who’ve stopped taking Prinzide

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Prinzide

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Prinzide

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Prinzide

Always
 1 50%
Usually
 1 50%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Prinzide

Very
 0 0%
Somewhat
 1 50%
A little
 0 0%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Prinzide

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.